Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
To evaluate and compare the relative plasma bioavailability and therefore the bioequivalence of two different immediate release products each containing Ribavirin 400 mg, after administering a single oral dose, to healthy adult subjects under fed conditions.
Epistemonikos ID: 1b1e15b4a7bb0d2d7293e483f9bebefc653c1f68
First added on: May 13, 2024